Date Published: July 15, 2008
Publisher: Public Library of Science
Abstract: The PLoS Medicine Editors discuss the requirements in the 2007 Food and Drug Administration Amendments Act for reporting of clinical trials results, and the role of journals.
Partial Text: 2008 has been a good year for access to research. Effective New Year’s Day, both the Canadian Institutes of Health Research  and the Howard Hughes Medical Institute  require publicly accessible archiving of papers published by their grantees. Also in January, the European Research Council announced its European Union–wide open-access mandate . In February, the Harvard Faculty of Arts and Sciences voted to give the University a worldwide license to exercise copyright in each faculty member’s scholarly articles for the purpose of making these articles freely available ; Harvard Law School committed to mandatory free access in May . In March, the European University Association endorsed open-access repositories , and in April the United States National Institutes of Health Public Access Policy  took effect, bringing America’s leading sponsor of biomedical research into the impressive circle of agencies that require archiving of papers resulting from the research they fund. Judging by the ever-increasing number of submissions to PLoS journals, authors appear to be voting with their manuscripts for open access to research.